Health Care & Life Sciences » Pharmaceuticals | Arbutus Biopharma Corp.

Arbutus Biopharma Corp.

Arbutus Biopharma Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.32
Market Cap
$127.91 M
Shares Outstanding
56.85 M
Public Float
33.5 M

Profile

Address
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
Canada
Employees -
Website http://www.arbutusbio.com
Updated 07/08/2019
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. .

Financials

View All

Mark J. Murray
President, Chief Executive Officer & Director
William T. Symonds
Executive Director & Chief Development Officer